4
Changes in Ownership
Vistagen Therapeutics, Inc. Filed Acc 0001415889-24-000344
CHIEF EXECUTIVE OFFICER acquired 167 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Singh Shawn CHIEF EXECUTIVE OFFICER | 2023-12-29 | Grant or award | +167 | $1.72 | $287 | 5,633 | D |
Loading xslF345X05/form4-01032024_100142.xml…